Status:
ACTIVE_NOT_RECRUITING
Functional Neuroimaging in Parkinson's Disease
Lead Sponsor:
University of Delaware
Conditions:
Parkinson Disease
Healthy Aging
Eligibility:
All Genders
45-85 years
Brief Summary
The study uses magnetic resonance imaging (MRI) to better understand changes in the brain underlying motor symptoms affecting upper and lower limbs in Parkinson's disease.
Detailed Description
There is a tremendous need to improve the understanding of the pathophysiology underlying motor symptoms in Parkinson's disease in order to optimize existing treatment options/develop new therapies. T...
Eligibility Criteria
Inclusion
- A clinical diagnosis of Parkinson's disease
- No neurological disorders if interested in participating as a control participant
- Must be capable of providing informed consent
- Must be eligible to receive a brain MRI
Exclusion
- A secondary movement disorder diagnosis in addition to Parkinson's disease
- Dementia
- Medical conditions that may make one ineligible for receiving a brain MRI
- Inability to provide informed consent
- Control/healthy group: neurological disorders
- Control/healthy group: cannot walk without an assistive device/mobility problems
Key Trial Info
Start Date :
September 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 2 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04904068
Start Date
September 15 2020
End Date
November 2 2025
Last Update
April 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Delaware
Newark, Delaware, United States, 19713